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Summary
Centralspindlin is essential for the formation of microtubule
bundle structures and the equatorial recruitment of factors
critical for cytokinesis [1, 2]. Stable accumulation of central-
spindlin at the spindle midzone requires its multimerization
into clusters [3] and Aurora B kinase activity [4–10], which
peaks at the central spindle during anaphase [11, 12].
Although Aurora B phosphorylates centralspindlin directly
[13–17], how this regulates centralspindlin localization is
unknown. Here we identify a novel regulatory mechanism
by which Aurora B enables centralspindlin to accumulate
stably at the spindle midzone. We show that 14-3-3 protein
binds centralspindlin when the kinesin-6 component
MKLP1 is phosphorylated at S710. 14-3-3 prevents central-
spindlin from clustering in vitro, and an MKLP1 mutant that
is unable to bind 14-3-3 forms aberrant clusters in vivo. Inter-
estingly, 14-3-3 binding is inhibited by phosphorylation of
S708, a known Aurora B target site that lies within the motif
bound by 14-3-3. S708 phosphorylation is required for
MKLP1 to stably localize to the central spindle, but it is
dispensable in an MKLP1 mutant that does not bind 14-3-3.
We propose that 14-3-3 serves as a global inhibitor of
centralspindlin that allows Aurora B to locally activate clus-
tering and the stable accumulation of centralspindlin
between segregating chromosomes.
Results and Discussion
Mutation of S710 Suppresses the Cytokinesis Defects
Associated with Mutation of S708, a Conserved Aurora B
Phosphorylation Site
To investigate the molecular mechanism by which Aurora B
regulates centralspindlin localization, we analyzed the role of
the most conserved Aurora B target site on centralspindlin
(Figure 1A) [15], S708 of MKLP1, in HeLa cells. We performed
knockdown and rescue assays and observed cell division via
time-lapse imaging (see Figures S1A and S1B available online).
After depletion of MKLP1, approximately 50% of cells failed
cytokinesis (Figure 1B). This defect was rescued by expres-
sion of wild-type GFP-MKLP1, but not by a mutant in which
S708 was substituted for alanine (Figure 1B), which is consis-
tent with previous work in Caenorhabditis elegans [15]. Forty
percent of the GFP-MKLP1-S708A-expressing cells that failed
cytokinesis only transiently localized GFP-MKLP1-S708A to
the spindle midzone without forming a midbody (Figure 1C,
middle), a phenotype similar to the depletion of a chromosomal
passenger complex (CPC) component [7]. The remaining 60%*Correspondence: m.mishima@gurdon.cam.ac.ukformed a midbody that appeared to fragment during late
division (Figure 1C, bottom). Importantly, these cytokinesis
defects are not due to differences in the level of transgene
expression (Figure 1D). Interestingly, sequence alignment
indicated that the serine residue 2 amino acids downstream
of S708, S710, is also highly evolutionarily conserved (Fig-
ure 1A), and a genome-wide phosphoproteome screen has
detected phosphorylation of S710 in vivo [18]. Expression of
a construct in which S710 was mutated to alanine rescued
cytokinesis as efficiently as the wild-type (Figure 1B, GFP-
MKLP1-S710A). Remarkably, when S710 was substituted for
alanine in addition to S708, the cytokinesis defects associated
with mutation of S708 were suppressed (Figure 1B, GFP-
MKLP1-S708A/S710A). These data indicate that phosphoryla-
tion of S708, a conserved and essential Aurora B target site, is
required to antagonize an activity mediated by phosphory-
lated S710 that prevents MKLP1 from stably accumulating at
the spindle midzone and forming a functional midbody.
14-3-3 Protein Binds MKLP1 at a Highly Conserved Motif
Centered on Phosphorylated S710
An explanation for this could be that an interaction partner of
MKLP1 is bound or released depending on the combinatorial
phosphorylation state of S708 and S710. To test this, we per-
formed a pull-down analysis with phosphopeptides covering
this region and found a band of approximately 30 kDa
specifically bound to S710-monophosphorylated peptide
(Figure 2A). Mass spectrometry analysis identified this band
to contain 14-3-3 zeta and gamma isoforms. 14-3-3 proteins
are ubiquitous and highly abundant phosphoserine- or phos-
phothreonine-binding proteins involved in multiple signal
transduction and cell-cycle events (reviewed in [19]), including
cytokinesis [20–22]. Centralspindlin has previously been
detected in screens for 14-3-3-interacting proteins [23–25],
but neither the sequence recognized by 14-3-3 nor the func-
tional role of this interaction has been addressed. We identi-
fied a highly conserved 14-3-3-binding motif encompassing
S708 and S710 of MKLP1 (Figure 2B), in which S710 is posi-
tioned at the phosphoserine/phosphothreonine essential for
14-3-3 binding. Endogenous 14-3-3 and centralspindlin bound
one another in reciprocal coimmunoprecipitation assays
(Figures 2C and 2D), and their interaction was sensitive to
phosphatase treatment (Figure 2E). This is consistent with
the phosphopeptide-binding pattern observed above and
the requirement of phosphorylation for mode 1 14-3-3 binding
[26]. S710 was essential for fragments of MKLP1 to interact
with human 14-3-3 zeta in yeast two-hybrid analyses
(Figure 2F; Figure S2), in which endogenous yeast kinases
presumably generate the phosphoepitope required for binding
[27]. To test whether phosphorylation of S710 is required
for 14-3-3 and MKLP1 to interact in vivo, we expressed full-
length myc-tagged MKLP1 mutants containing alanine substi-
tutions at S708 and/or S710. Whereas wild-type MKLP1
and MKLP1-S708A both coimmunoprecipitated with 14-3-3,
neither MKLP1-S710A nor MKLP1-S708A/S710A did so
(Figure 2G). Thus, phosphorylated S710, the function of which
is antagonized by phosphorylated S708 (Figure 1), is essential
for centralspindlin to bind 14-3-3 (Figure 2).
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Figure 1. Cytokinesis Defects Caused by Mutation of S708, an Aurora B Phosphorylation Site on MKLP1, Are Suppressed by the Additional Mutation of S710
(A) Sequence alignment indicates that both S708 and S710 of Homo sapiens MKLP1 are highly conserved across the animal kingdom.
(B) Quantitation of cytokinesis failures from live cell recordings of HeLa cells treated with MKLP1 small interfering RNA (siRNA) and transfected with GFP
vector or the MKLP1 variants as indicated. Data show the percentage of cells that failed cytokinesis averaged from three independent experiments in which
at least 85 GFP-MKLP1- or 64 GFP-expressing cells were analyzed (see Figure S1 for details). Error bars indicate the standard deviation.
(C) Stills taken from the films quantitated in (B) showing the localization of wild-type (WT) MKLP1 and MKLP1-S708A. MKLP1-S708A either transiently local-
ized to the central spindle (arrows) or condensed to form a midbody, which then fragmented (arrowhead). Numbers indicate time after anaphase onset (min).
(D) Equal expression of transgenes was confirmed by western blotting whole-cell lysate with anti-GFP or anti-tubulin antibody as indicated.
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Cytokinesis
Importantly, 14-3-3 did not bind MKLP1 peptides when S708
was phosphorylated (Figure 2A),perhaps because a phosphate
group at this position is incompatible with the architecture of
the 14-3-3 peptide-binding pocket [28]. This suggests that
the relative levels and subcellular distribution of S708- and
S710-phosphorylated MKLP1 determine the temporal and
spatial patterns of 14-3-3 binding. To investigate these, we
generated three phosphospecific antibodies recognizing
S708-monophosphorylated (pS708), S710-monophosphory-
lated (pS710), or S708- and S710-diphosphorylated (pS708/
710) MKLP1. Each of these antibodies is highly specific for
the MKLP1 peptide against which it was raised (Figures S3A–
S3E). We could detect all three S708- and S710-phosphory-
lated forms of MKLP1 in HeLa cells released from nocoda-
zole-induced prometaphase arrest (Figure 3A). Both forms
containing phosphorylated S708 remained constant until cells
completed furrowing (90 to 150 min after release), and then
they declined dramatically. This decrease is consistent with
previous work on S708 monophosphorylation [15] and a
reported global decrease in Aurora B activity after anaphase
onset [12]. In contrast, S710 appeared to be constitutively
phosphorylated as levels of pS710-MKLP1 followed those of
total MKLP1 after release from an S-phase block (Figure S3F)and were relatively unchanged throughout mitosis and cytoki-
nesis, even as cells completed division (Figure 3A). Thus,
although all three forms of S708- and S710-phosphorylated
MKLP1 coexist during cell division, levels of 14-3-3 binding-
competent S710-monophosphorylated MKLP1 and 14-3-3
binding-incompetent S708-phosphorylated MKLP1 are differ-
entially regulated.
To determine whether these phosphorylated forms show
different subcellular distributions, we immunostained dividing
HeLa cells. pS708-MKLP1 and pS708/710-MKLP1 clearly
colocalized with Aurora B accumulated at the central spindle
and midbody (Figures 3B and 3C). In contrast, pS710-MKLP1
was not enriched at the central spindle and early midbody
(Figure 3B). This distinct subcellular distribution suggests that
S710-monophosphorylated centralspindlin is less active than
S708-phosphorylated forms, which strongly accumulate at the
central spindle. Interestingly, pS710-MKLP1 became enhanced
at the late midbody, which is intriguing given a recently
proposed abscission checkpoint involving Aurora B [29] and
the functional linkage of S710 with S708, an Aurora B target
site (Figure 1). Importantly, phosphorylation of S708 at the
central spindle required colocalization of MKLP1 with Aurora
B because depletion of MKLP2, a mitotic kinesin that is neces-
sary for Aurora B to localize to the spindle midzone [9, 30],
abolished pS708/pS710-MKLP1 from this structure (Figure 3C).
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Figure 2. 14-3-3 Protein Binds MKLP1 at a Motif
Centered on Phosphorylated S710
(A) MKLP1 peptides phosphorylated as indicated
were incubated with mitotic HeLa cell lysate.
Bound proteins were separated by SDS-PAGE
and visualized by silver stain. An asterisk marks
the band identified to contain 14-3-3 zeta and
gamma. ‘‘Unphospho’’ denotes unphosphory-
lated. Input is 10% of the lysate used for each
pull-down.
(B) Comparison of the mode 1 14-3-3 binding
consensus sequence bound by 14-3-3 with the
sequence surrounding S708 and S710 indicates
the presence of an evolutionarily conserved
14-3-3 binding site.
(C) MKLP1 was immunoprecipitated from the
microtubule-bound fraction of mitotic HeLa cells
in the presence or absence of a blocking peptide,
and bound proteins were probed for 14-3-3 by
western blotting.
(D) 14-3-3 was immunoprecipitated from mitotic
HeLa cell extract, and bound proteins were
probed for MKLP1 or MgcRacGAP, the nonmotor
component of the centralspindlin complex [36],
as indicated. The two bands detected for
MKLP1 are MKLP1 and its minor splicing variant
containing an extra exon [37].
(E) 14-3-3 was immunoprecipitated from mitotic
HeLa cell extract in the presence or absence of
alkaline phosphatase, and bound proteins were
probed for MKLP1.
(F) Yeast two-hybrid analyses were performed
with amino acids 690–856 of MKLP1 and full-
length human 14-3-3 zeta. Growth on medium lacking histidine and supplemented with 3-aminotriazol (3AT) indicates an interaction between proteins fused
to the activation domain (AD) and DNA-binding domain (DB). Alanine substitution at S710 (3 and 4), but not at S708 (2), abolished the interaction between
MKLP1 and 14-3-3 (1). See Figure S2 for controls.
(G) HeLa cells were transfected with myc-tagged MKLP1 variants as indicated or GFP as a control. 14-3-3 was immunoprecipitated from mitotic extract, and
bound MKLP1 was detected with an anti-myc antibody.
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Collectively, these data indicate that pS710-MKLP1 and both
forms of S708-phosphorylated MKLP1 coexist during mitosis
and cytokinesis but are differentially regulated temporally and
spatially depending on the distribution and activity of Aurora
B. Importantly, these differences correlate with the ability to
bind 14-3-3 (Figure 2A), which suggests that the 14-3-3-
MKLP1 interaction is spatially regulated by Aurora B-mediated
phosphorylation of S708. To test this, we determined whether
levels of S710-monophosphorylated MKLP1, to which 14-3-3
binds, change in the absence of active Aurora B. We fixed
and stained cells undergoing cytokinesis after brief treatment
with ZM447439, a specific Aurora kinase inhibitor. Whereas
Aurora inhibition reduced both S708-phosphorylated forms of
MKLP1 at the midbody, pS710-MKLP1 was increased by
more than 2-fold (Figure 3D). Similar changes were observed
by immunoblotting MKLP1 from Aurora-inhibited cell lysate
(Figure 3E). These data strongly suggest that Aurora B phos-
phorylates S708, but not S710, which seems to be phosphory-
lated by a constitutively active and ubiquitous kinase (Figures
3A and 3B; Figure S3F). Remarkably, Aurora inhibition also
led to an enhancement of the MKLP1-14-3-3 interaction
(Figure 3F). From these data, we propose that Aurora B inhibits
binding of 14-3-3 to MKLP1 at the central spindle and midbody
by phosphorylating S708 and so decreasing the level of S710-
monophosphorylated MKLP1, to which 14-3-3 binds. Consid-
ering that S708 phosphorylation is dispensable for cytokinesis
in the absence of S710 and thus 14-3-3 binding (Figure 1; Fig-
ure 2), this model suggests that 14-3-3 inhibits centralspindlinand that the role of S708 phosphorylation is to remove 14-3-3.
In the context of a previous study [31], this suggests that phos-
phorylation of the first serine of the mode 1 motif is a general
mechanism by which 14-3-3 binding can be regulated.
14-3-3 Inhibits Clustering of Centralspindlin
What is the centralspindlin function that is inhibited by 14-3-3?
For stable localization to the spindle midzone and accumula-
tion into the midbody matrix, centralspindlin heterotetramers
must multimerize into clusters of varying size that travel along
microtubules and accumulate at plus ends [3]. Aurora B is
likely to regulate this process because inactivation [6–8] or
mislocalization [10] of the CPC results in the unstable localiza-
tion of centralspindlin to the spindle midzone, which is also
observed in a clustering-defective centralspindlin mutant [3].
Mutation of S708 of MKLP1 in human cells causes a similar
phenotype (Figure 1). Therefore, we investigated whether
14-3-3 binding might directly affect the assembly of central-
spindlin clusters, which can be detected as a decrease in solu-
bility under physiological conditions. MKLP1-S710A, which
cannot bind 14-3-3, was significantly less soluble than
wild-type MKLP1 in crude cell lysate (Figure 4A). Moreover,
in knockdown and rescue assays (Figure 1), we observed
punctate aggregates of strongly expressed GFP-MKLP1-
S710A after nuclear envelope breakdown (Figure 4B; 14 of 19
cells), but not of wild-type GFP-MKLP1 expressed at a similar
or higher level (1 of 12 cells). These aggregates of MKLP1-
S710A formed in the presence of ZM447439 and are therefore
assembled independently of Aurora B (data not shown). Thus,
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Figure 3. Aurora B Phosphorylates S708 of MKLP1 at the Central Spindle and Midbody and Inhibits the MKLP1-14-3-3 Interaction
(A) Synchronized HeLa cells were released from a nocodazole block to progress through mitosis and were collected at the times shown. MKLP1 was then
immunoprecipitated and probed with phosphospecific antibodies as indicated.
(B) HeLa cells were synchronized by single thymidine block and release and then fixed and stained in mitosis and cytokinesis with antibodies to tubulin and
phosphorylated MKLP1 as indicated.
(C) HeLa cells were subjected to luciferase or MKLP2 siRNA, synchronized by a single thymidine block and release, and then fixed and stained for Aurora B
and total or phosphorylated MKLP1 as indicated.
(D) HeLa cells synchronized by a single thymidine block and release were allowed to progress to cytokinesis, were treated with the Aurora inhibitor
ZM447439 (ZM), and were then fixed and stained for total or phosphorylated MKLP1 as indicated. Data show the fold change in midbody intensity in the
presence of Aurora inhibitor relative to its absence averaged from three independent experiments, with at least 27 midbodies measured per sample. Error
bars show the standard deviation. p values were calculated via Student’s t test.
(E) HeLa cells were synchronized by double thymidine block and release and then arrested in mitosis with nocodazole in the presence or absence of the
Aurora inhibitor ZM447439. MKLP1 was immunoprecipitated from extract and probed for total or phosphorylated MKLP1.
(F) Cells were synchronized, arrested, and inhibited as in (E). 14-3-3 was then immunoprecipitated from extract and probed for bound MKLP1 or MgcRac-
GAP as indicated.
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93014-3-3 binding is necessary to prevent aberrant clustering of
centralspindlin.
To determine whether 14-3-3 is sufficient to prevent cluster
formation, we purified native centralspindlin competent for
binding to 14-3-3 (Figure 4C) from mitotic HeLa cells in the
presence of high salt. We induced clustering by diluting this
complex to physiological salt in the presence of either 14-3-
3 or bovine serum albumin (BSA) as a control. Centralspindlin
was rendered almost completely soluble by 14-3-3, whereasit was mostly insoluble and clustered in the presence of
BSA (Figure 4D). Importantly, this 14-3-3-bound centralspin-
dlin showed significantly weaker microtubule bundling
activity (Figure 4E), consistent with the effect of clustering
on the processive motility and microtubule bundling activity
of centralspindlin [3]. We conclude that 14-3-3 binding is
necessary and sufficient to sequester centralspindlin dis-
persed throughout the cytoplasm in an inactive, unclustered
form.
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Figure 4. 14-3-3 Regulates the Clustering of
Centralspindlin
(A) HeLa cells were transiently transfected with
myc-tagged MKLP1 constructs, as indicated,
and were arrested in mitosis with nocodazole.
The levels of myc-tagged MKLP1 in total (T)
extract prepared under physiological concentra-
tions of salt were compared with those that
remained in the soluble fraction (S) after centrifu-
gation.
(B) Stills from knockdown and rescue experi-
ments (Figure 1) show aggregates of GFP-
MKLP1-S710A (arrowheads) in prometaphase.
Numbers indicate the time after nuclear envelope
breakdown (min).
(C) GST and GST-14-3-3 were incubated with
native centralspindlin that was purified as
a soluble heterotetramer in the presence of high
salt from nocodazole-arrested HeLa cells treated
with ZM447439 (see Experimental Procedures).
Bound proteins were probed for MKLP1 and
MgcRacGAP by western blotting, as indicated.
(D) Native centralspindlin was purified as in (C).
Clustering was then induced by diluting to phys-
iological salt in the presence of recombinant
14-3-3 zeta or bovine serum albumin (BSA) as
a control. Following centrifugation, the amount
remaining in the soluble fraction (S) was
compared with that in the total fraction (T) by
Coomassie staining.
(E) Purified GFP-tagged centralspindlin was incu-
bated with 14-3-3 zeta or BSA as in (D) and then
mixed with rhodamine- and biotin-labeled micro-
tubules stabilized with taxol. Microtubules were
immobilized on avidin-coated coverslips and
were observed without fixation. Bundling activity
was quantified based on rhodamine fluorescence
per unit length of single or bundled microtubules
(see Experimental Procedures for details). Error
bars indicate the standard error of the mean.
(F) A model for 14-3-3- and Aurora B-regulated
clustering of centralspindlin. Whereas 14-3-3-
bound centralspindlin is dispersed and only tran-
siently bound to microtubules (MT), removal of
14-3-3 by Aurora B causes centralspindlin to
cluster, which in turn enables stable association
with and bundling of microtubules at the spindle
midzone.
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Activation of a Positive Feedback Loop by Aurora B
Here we have described a novel mechanism in which Aurora B
and 14-3-3 coordinately regulate clustering of centralspindlin
and control its stable accumulation to the spindle midzone
(Figure 4F). This scheme explains our finding that the cytoki-
nesis defects associated with MKLP1-S708A are suppressed
when S710 is additionally mutated to alanine (Figure 1). Modu-
lation of oligomeric state is a new mechanism to regulate the
activity of kinesin-like motor proteins. Furthermore, regulation
of protein multimerization is a novel and potentially widely
applicable mode of action by which 14-3-3 can attenuate
target protein activity. The molecular mechanism by which
14-3-3 inhibits centralspindlin clustering instead of promoting
it by crosslinking MKLP1 dimers will be the focus of future
research.
We havepreviouslyproposeda model to explain how central-
spindlin steeply accumulates to the central spindle, in which
clustering plays a critical role [3]. Cluster formation is enhanced
when local concentrations of MKLP1 are high. As clusteringfacilitates the accumulation of MKLP1 to microtubule plus-
ends, which in turn increases its local concentration, this gives
rise to a positive feedback loop that is maximal at regions of
antiparallel microtubule overlap. Although positive feedback
enables rapid responses to regulatory switches and sharp
spatial macromolecular gradients, it can result in instability
and sensitivity to random fluctuations in local protein concen-
tration. The regulatory pathway we have described enables
clustering and therefore positive feedback to be globally buff-
ered by 14-3-3 and locally activated by the CPC (Figure 4F).
This pathway predicts that the accumulation of centralspindlin
should correlate with the position and activity of Aurora B. This
is indeed the case: centralspindlin and the CPC colocalize at
ectopic Rappaport furrows in fused mammalian cells [32],
and, during monopolar cytokinesis, MKLP1 accumulates where
the CPC is concentrated, but only when Aurora B is active [33].
We propose that, in concert with temporal regulation by CDK1
kinase [34, 35], the regulation of centralspindlin by Aurora B and
14-3-3 helps to maintain genomic stability by spatially coordi-
nating cytokinesis with chromosome segregation.
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Pull-Down Analysis with MKLP1 Phosphopeptides
The peptide sequences used were NAPPIRLRHRRSRSAGDRWVDHKPAS,
NAPPIRLRHRRpSRSAGDRWVDHKPAS, NAPPIRLRHRRSRpSAGDRWVD
HKPAS, and NAPPIRLRHRRpSRpSAGDRWVDHKPAS, where pS denotes
phosphoserine. Peptides were synthesized to greater than 95% purity
with a biotin tag conjugated to the N terminus and immobilized on M-280
streptavidin dynabeads (Invitrogen). Nocodazole-arrested HeLa cells were
lysed in buffer containing 20 mM PIPES (pH 7), 2 mM EGTA, 2 mM MgCl2,
0.1% (v/v) Triton X-100, 1 mM dithiothreitol (DTT), 10 mg/ml leupeptin,
10 mg/ml pepstatin, 1 mM phenylmethanesulphonylfluoride, 20 mM NaF,
5 mM microcystin, and 150 mM NaCl. Extract was clarified by centrifugation
and mixed with peptide-coupled beads for 2 hr with rotation at 4C. Beads
were washed three times with lysis buffer, and bound proteins were run on
SDS-PAGE. After silver staining, proteins contained within a band of interest
were identified by mass spectroscopy.
In Vitro Assays with Centralspindlin Holocomplex
GFP-FLAG-tagged MKLP1 stably expressed in HeLa cells was purified as
described [3]. For the 14-3-3 binding assay, tagged holocomplex was
incubated for 2 hr with GST-14-3-3 or GST beads in the buffer described
for peptide pull-down analysis. After washing, bound protein was probed
for MKLP1 or MgcRacGAP [36] by western blotting as indicated. For solu-
bility analysis, untagged holocomplex was diluted into a reaction mixture
finally containing 30 mg/ml centralspindlin, 0.25 mg/ml of either BSA or
recombinant human 14-3-3 zeta, 100 mM NaCl, 1.3 mM MgCl2, 1.3 mM
EGTA, 0.1 mM EDTA, 0.01% (w/v) Triton X-100, 0.4 mM DTT, 3 mM ATP,
10 mM PIPES, and 5 mM HEPES (pH 7). After incubation at room tempera-
ture for 30 min, the sample was centrifuged at 14,000 rpm (k factorw50) for
30 min at 4C and analyzed by SDS-PAGE and Coomassie staining. For
microtubule bundling assays, GFP-tagged centralspindlin complex
affinity-purified with the FLAG tag was diluted (final 2 mg/ml) in the reaction
mixture above supplemented with 10 mM DTT and 1 mM ATP and mixed
with taxol-stabilized microtubules polymerized in vitro from a mixture of un-
labelled or rhodamine-labeled bovine tubulin, as well as biotin tubulin. This
was incubated with a coverglass that had been coated sequentially with
biotin-labeled BSA and neutravidin (Molecular Probes) and was visualized
with fluorescence microscopy. For quantification of microtubule bundling,
the integrated intensity of rhodamine fluorescence per unit length of micro-
tubules or microtubule bundles (r) was measured for six areas (randomly
chosen from a sample containing >450 microtubules or bundles in total)
with ImageJ, and the equivalent value for unbundled microtubules (r0)
was subtracted. Bundling activity consists of this value normalized to r0,
i.e., (r – r0)/r0, and indicates the average number of microtubules added
to a single microtubule by bundling.
For additional experimental procedures, please refer to the Supplemental
Experimental Procedures.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at doi:10.1016/
j.cub.2010.03.055.
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